Access to Medicines

CHA

Tag: Access to Medicines

MSF and global TB activists take stage at annual TB conference

Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali, Indonesia, over 70 TB activists, including...

Read more

Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen

80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors Without Borders (MSF) called on...

Read more

‘Time for $5’ campaign to deliver 206,937 signatures to US corporation Danaher in Washington, DC, demanding a $5 price for their medical tests

US test maker Cepheid and parent corporation Danaher have ignored global calls for price reductions and have broken their promise from one year ago to be transparent about what it costs to make their medical tests Washington, DC, 17 October...

Read more

United States: MSF resumes support to local groups helping migrants in Arizona desert

Doctors Without Borders/Médecins Sans Frontières(MSF) is resuming its work in support of Tucson-based nonprofit groups that are bringing humanitarian aid to migrants and asylum seekers crossing the US-Mexico border near the Sonoran Desert, the organization announced today. Earlier this year, a...

Read more

MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug

Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without...

Read more

Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health

Geneva, 17 June 2024 - In September 2023, the US corporation Danaher, which owns diagnostics maker Cepheid, announced a price reduction of the primary GeneXpert test used to diagnose tuberculosis (TB), from US$9.98 to $7.97, amid pressure from TB activists....

Read more

Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe

Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...

Read more

Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines

Where are we now? This week, on 6-7 June 2024, the Board of Gavi, the Vaccine Alliance, is meeting in Geneva to approve and endorse the one-page framework for Gavi 6.0, which outlines its strategy for the five-year period from...

Read more

MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions

Geneva/New Delhi, 15 February 2024 — In a welcome move today, the Indian Commerce Ministry confirmed its rejection of Switzerland's demand for data exclusivity for medicines in the India-EFTA trade deal, and emphasised the importance of protecting the country’s generic...

Read more

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is

Text leaked yesterday shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws.Geneva/New Delhi, 14 February 2024 — Following news that India and the European Free Trade Association (EFTA) – which...

Read more

MSF warns governments are failing to test, treat and prevent TB in children

Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease  Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF)  welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...

Read more

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries

30 September 2023, Geneva Christophe Perrin, TB Advocacy Pharmacist, MSF Access Campaign: “We welcome Johnson & Johnson’s (J&J) announcement finally paving the way for unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis (DR-TB) who need...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons